$SEM (Select Medical Holdings Corporation)

$SEM {{ '2016-04-01T04:15:28+0000' | timeago}} • Announcement

$SEM reported that the Stock Purchase Agreement provides for an earn-out of up to $7.5MM payable to Select Medical Corporation if the contract therapy business meets some revenue thresholds from 2016 to 2018. Stephens Inc. acted as financial advisor to $SEM.

$HLS {{ '2017-07-20T13:56:35+0000' | timeago}} • Announcement

The BoD of $HLS declared a quarterly cash dividend on its common stock of $0.25 per share. The dividend is payable on Oct. 16, 2017, to stockholders of record on Oct. 2, 2017.

$INCY {{ '2017-07-20T13:24:37+0000' | timeago}} • Announcement

$INCY said first patient has been treated in Phase 3 trial of itacitinib for the first-line treatment of patients with acute graft-versus-host disease (GVHD). GVHD is a condition that might occur after an allogeneic transplant, whereby the donated bone marrow or peripheral blood stem cells view the recipient’s body as foreign and attack the body.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$TBPH {{ '2017-07-20T12:32:48+0000' | timeago}} • Announcement

$TBPH and $MYL announced positive results from a 12-month Phase 3 safety study of revefenacin in patients with chronic obstructive pulmonary disease (COPD). The study of 1,055 patients with COPD demonstrated that revefenacin was generally well-tolerated, and no new safety issues were identified.

$UHS {{ '2017-07-19T22:35:19+0000' | timeago}} • Announcement

$UHS BoD approved a cash dividend of $0.10 per share on Sept. 15, 2017 to shareholders of record as of Sept. 1, 2017.

$AKRX {{ '2017-07-19T21:41:28+0000' | timeago}} • Announcement

Specialty generic pharmaceutical company $AKRX said that its shareholders have voted to approve the merger for the acquisition of Akorn by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA. The companies expect the acquisition to close by early 2018.

$AGN {{ '2017-07-19T15:54:53+0000' | timeago}} • Announcement

$AGN appointed Joseph Boccuzi to its BoD, effective immediately. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Officer Practices at Spencer Stuart, following 24 years of service with the global executive search and leadership consulting firm.

$PRGO {{ '2017-07-17T13:30:02+0000' | timeago}} • Announcement

$PRGO received final approval from the FDA for its AB rated Abbreviated New Drug Application referencing $ABBV's Androgel Topical Gel, 1.62% packets. The gel is an androgen indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$MYL {{ '2017-07-14T12:05:52+0000' | timeago}} • Announcement

Pharma firm $MYL said the FDA Oncologic Drugs Advisory Committee has recommended approval of the biosimilar trastuzumab developed by Mylan along with India-based Biocon Ltd. for  treatment of breast cancer. The committee determined no clinically meaningful differences exist between the biosimilar product and cancer drug Herceptin.

$AMGN {{ '2017-07-13T12:24:26+0000' | timeago}} • Announcement

$AMGN and $AGN announced they will discuss data supporting the ABP 215 Biologics License Application (BLA) with FDA's Oncologic Drugs Advisory Committee. ABP 215 is a biosimilar candidate to Avastin (bevacizumab) and is the first bevacizumab biosimilar candidate to be considered by the FDA.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

$DVA {{ '2017-07-13T12:17:02+0000' | timeago}} • Announcement

DaVita Medical Group, a division of $DVA, acquired Dr. Rahn Shaw's practices, Park Avenue Medical Inc. and Winter Park Health Center Inc., each located in Orlando. Dr. Shaw has been an affiliate with DaVita Medical Group since 2005. Under the terms, the practices will be branded "DaVita Medical Group".

$QHC {{ '2017-07-12T19:46:10+0000' | timeago}} • Announcement

$QHC's affiliate signed a letter of intent to sell 72-bed L.V. Stabler Memorial Hospital in Greenville, Alabama and its associated assets, to the City of Greenville, Alabama. The divestiture is expected to close by Sept. 30, 2017.

$CYH {{ '2017-07-12T11:46:04+0000' | timeago}} • Announcement

Hospital operator $CYH said its subsidiaries have signed a definitive agreement to sell Weatherford Regional Medical Center in Texas, and its associated assets, to the subsidiaries of $HCA. The transaction is expected to close later this year. The company is planning to divest a total of 30 hospitals.

$HCA {{ '2017-07-11T22:05:57+0000' | timeago}} • Announcement

$HCA announced an agreement to acquire Weatherford Regional Medical Center outside Fort Worth, Texas, from subsidiaries of Community Health Systems, Inc. The transaction, which is subject to regulatory approvals and other closing conditions, is expected to close by the fall of 2017.

$SEM {{ '2017-07-11T15:58:57+0000' | timeago}} • Announcement

$SEM subsidiary Select Medical Corp. has opened a new rehabilitation hospital, in a joint venture partnership with SSM Health.  SSM Health Rehabilitation Hospital - Lake Saint Louis, which offers rehabilitation care for acute medical conditions, is the first such facility having a brain injury unit.

$HLS {{ '2017-07-11T10:50:33+0000' | timeago}} • Announcement

$HLS expects the total rebranding investment to be about $25-30MM, to be incurred between 2017 and 2019. About $7-10MM is expected to be incurred in 2017, of which $6-8MM will be operating expenses and $1-2MM will be capital expenditures. Only $1MM of this investment is included in 2017 forecast which will be updated in 2Q17 results.

$HLS {{ '2017-07-11T10:46:49+0000' | timeago}} • Announcement

$HLS said it will change its name to Encompass Health Corp., effective Jan. 2, 2018. The corporate name change will be accompanied by a NYSE ticker symbol change, from $HLS to "EHC". Beginning in 1Q18, both business segments will begin transitioning to the Encompass Health name.

$AGN {{ '2017-07-10T16:14:16+0000' | timeago}} • Announcement

$AGN announced additional results of a prespecified prospective pooled subgroup analysis from the two Phase 3 studies, which evaluated the efficacy and safety of Viberzi to treat the symptoms associated with irritable bowel syndrome with diarrhea, abdominal pain and diarrhea.

Recent Transcripts

USPH (US Physical Therapy Inc.)
Thursday, June 29 2017 - 2:30pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
QHC (Quorum Health Corporation)
Monday, May 15 2017 - 3:00pm
MYL (Mylan N.V.)
Wednesday, May 10 2017 - 2:00pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
GEN (Genesis Healthcare, Inc.)
Tuesday, May 9 2017 - 2:00pm
BKD (Brookdale Senior Living Inc.)
Tuesday, May 9 2017 - 2:00pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
FVE (Five Star Quality Care Inc.)
Friday, May 5 2017 - 2:00pm
SEM (Select Medical Holdings Corporation)
Friday, May 5 2017 - 1:00pm
MD (MEDNAX, Inc.)
Thursday, May 4 2017 - 2:00pm
INCY (Incyte Corporation)
Thursday, May 4 2017 - 2:00pm
KND (Kindred Healthcare Inc.)
Thursday, May 4 2017 - 1:00pm
FMS (Fresenius Medical Care AG & Co. KGAA)
Wednesday, May 3 2017 - 1:30pm
DVA (DaVita HealthCare Partners Inc.)
Tuesday, May 2 2017 - 9:00pm
EVHC (Envision Healthcare Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
HCA (HCA Holdings, Inc.)
Tuesday, May 2 2017 - 3:00pm
THC (Tenet Healthcare Corp.)
Tuesday, May 2 2017 - 2:00pm
ENSG (The Ensign Group, Inc.)
Monday, May 1 2017 - 5:00pm
LPNT (LifePoint Health, Inc.)
Friday, April 28 2017 - 2:00pm

AlphaGraphics you may like